Background: Dual antiplatelet therapy is the standard of care for acute coronary syndrome, but uncertainty exists regarding the optimal regimen for patients in North America. We sought to compare the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback